Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Test Predict Success of IVF Treatment

By HospiMedica International staff writers
Posted on 14 Sep 2010
A new forecast model can predict the outcomes of a subsequent round of in vitro fertilization (IVF) for those women who have already gone through one cycle, claims a new study. More...


Researchers at Stanford University School of Medicine (CA, USA) retrieved data from 1,676 IVF cycles performed at Stanford Hospital (CA, USA) between 2003 and 2006 and identified 52 factors--such as patient age, levels of certain hormones, number and quality of eggs, and individual characteristics of each embryo--that influence a woman's chance of having a baby. They then developed a computer model that sorted patients into subsets defined by deep phenotyping similar clinical characteristics to predict live-birth probabilities in a subsequent round of IVF. According to the researchers, the new test not only integrates more data into its methodology, but also measures a different outcome: live birth instead of pregnancy.

When testing their model with data from a separate set of more than 600 IVF treatments performed in 2007-08, the researchers determined that the model's predictions were significantly different from the age-based predictions in 60% of patients. Interestingly, out of this group, more than half were assigned greater odds of having a baby than what age-related data indicated. When further verifying the accuracy of the new method, the researchers were able to determine that their model predicted outcomes with 1,000 times more accuracy than age-based guidelines. The study was published early online on July 19, 2010, in the Proceedings of the [U.S.] National Academy of Sciences (PNAS).

"Our findings show that the first IVF cycle can provide quantitative, customized prediction of the live birth probability in a subsequent cycle. This concept is radically different from the current paradigm, in which age is a major predictor,” said study coauthor Lynn Westphal, M.D., an associate professor of obstetrics and gynecology. "For some of the patients, we may be able to reassure them and help them move forward and do another cycle if they have good odds. For other patients, if they're in a poor category, we'll help them move on to consider better options.”

IVF is a process by which egg cells are fertilized by sperm outside the womb, and is a major treatment in infertility when other methods of assisted reproductive technology have failed. The process involves hormonally controlling the ovulatory process, removing eggs from the woman's ovaries, and letting sperm fertilize them in a fluid medium. The fertilized egg (zygote) is then transferred to the patient's uterus with the intent to establish a successful pregnancy. The first successful birth of a colloquially termed "test tube baby,” a girl named Louise Brown, occurred in 1978 in Oldham (United Kingdom).

Related Links:

Stanford University School of Medicine
Stanford Hospital



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical-Grade Display
HL2316SHTB
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.